Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Prostate Cancer treatment details. Chemotherapy. Princess Margaret Hospital, Ontario, Canada



Survival: N/R
   
Toxicity Grade: 3
   
Treatments: Chemotherapy
   
Drugs:
Country: Canada
   
City/State/Province: Ontario
   
Hospital: Princess Margaret Hospital
   
Journal: Link
   
Date: 9/2005

Description:
Patients: This Phase II study involved 40 men with hormone resistent prostate cancer. 21 patients had prior radiation therapy and 26 had prior hormone therapy. Metastatic sites included bone, liver, lung, and lymph nodes.

Treatment: The treatment consisted of a chemotherapy drug Gefitinib (Iressa).

Toxicity: Grade 1-3 toxicities included fatigie. Grade 1-2 toxicities included: anorexia, diarrhea, nausea, stomatitis, taste disturbance, and rash.

Results: None of the patients demonstrated a PSA or objective measurable response. The median overall survival was not reported.

Support: The study was supported by AstraZeneca Pharmaceuticals and the NCI of Canada. AstraZeneca manufactures and/or markets Gefitinib.

Correspondence: Malcolm J. Moore, MD

E-mail to a Friend Email Physician More Information